Curative Biotechnology CUBT Stock
Curative Biotechnology Price Chart
Curative Biotechnology CUBT Financial and Trading Overview
| Curative Biotechnology stock price | 0.01 USD |
| Previous Close | 0.03 USD |
| Open | 0.03 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.03 - 0.03 USD |
| 52 Week Range | 0.0051 - 0.04 USD |
| Volume | 5K USD |
| Avg. Volume | 209.37K USD |
| Market Cap | 15.65M USD |
| Beta (5Y Monthly) | 224.591 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CUBT Valuation Measures
| Enterprise Value | 18.95M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.444 |
Trading Information
Curative Biotechnology Stock Price History
| Beta (5Y Monthly) | 224.591 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.0051 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.02 USD |
CUBT Share Statistics
| Avg. Volume (3 month) | 209.37K USD |
| Avg. Daily Volume (10-Days) | 126.84K USD |
| Shares Outstanding | 537.88M |
| Float | 1.25M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -179.94% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -4264665 USD |
| Net Income Avi to Common (ttm) | -6016113 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 636 USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 846.55K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.008 |
| Book Value Per Share (mrq) | -13.378 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2251158 USD |
| Levered Free Cash Flow (ttm) | -192686 USD |
Profile of Curative Biotechnology
| Country | United States |
| State | FL |
| City | Boca Raton |
| Address | 1825 NW Corporate Boulevard |
| ZIP | 33431 |
| Phone | 561 907 8990 |
| Website | https://curativebiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor; and Metformin Reformulation for the treatment of degenerative eye disease. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. The company was formerly known as Connectyx Technologies Holdings Group, Inc. and changed its name to Curative Biotechnology, Inc. in November 2020. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida.
Q&A For Curative Biotechnology Stock
What is a current CUBT stock price?
Curative Biotechnology CUBT stock price today per share is 0.01 USD.
How to purchase Curative Biotechnology stock?
You can buy CUBT shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Curative Biotechnology?
The stock symbol or ticker of Curative Biotechnology is CUBT.
Which industry does the Curative Biotechnology company belong to?
The Curative Biotechnology industry is Biotechnology.
How many shares does Curative Biotechnology have in circulation?
The max supply of Curative Biotechnology shares is 1.03B.
What is Curative Biotechnology Price to Earnings Ratio (PE Ratio)?
Curative Biotechnology PE Ratio is now.
What was Curative Biotechnology earnings per share over the trailing 12 months (TTM)?
Curative Biotechnology EPS is -0.01 USD over the trailing 12 months.
Which sector does the Curative Biotechnology company belong to?
The Curative Biotechnology sector is Healthcare.